PRODUCTION OF INFLAMMATORY CYTOKINES BY EPSTEIN-BARR-VIRUS (EBV)-INFECTED LYMPHOBLASTOID CELL-LINES SPONTANEOUSLY ORIGINATED FROM THE PERIPHERAL-BLOOD OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
S. Roncella et al., PRODUCTION OF INFLAMMATORY CYTOKINES BY EPSTEIN-BARR-VIRUS (EBV)-INFECTED LYMPHOBLASTOID CELL-LINES SPONTANEOUSLY ORIGINATED FROM THE PERIPHERAL-BLOOD OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, Clinical immunology and immunopathology, 77(2), 1995, pp. 162-171
In this study we have raised spontaneous Epstein-Barr virus (EBV)-posi
tive lymphoblastoid cell lines (LCL) from the peripheral blood of huma
n immunodeficiency virus (HIV)-infected individuals and of control pat
ients with primary EBV infections. These LCLs were also raised in the
presence of the viral inhibitor phosphonoformate (PFA); under these co
nditions, the in vitro infection of bystander B lymphocytes with EBV r
eleased in culture by in vivo infected B cells is inhibited. Thus, the
latter LCLs are likely to represent the progeny of B cells latently i
nfected by EBV in vivo. The LCLs raised in the presence or absence of
PFA had the same phenotypic features, type of EBV latency, and growth
pattern irrespective of whether they had been raised from HIV-seroposi
tive individuals or patients with primary EBV infections or had been g
enerated by infecting normal B cells in vitro. Studies on the producti
on of inflammatory cytokines were conducted by Northern blotting or by
determining the cytokine concentrations in the cell supernatants by i
mmunoassays or bioassays. Three of eight LCLs from HIV-seropositive pa
tients released TNF alpha and 5/5 released TNF beta, IL6 was present i
n the supernatants of 1/8 LCLs, and IL1 alpha and IL1 beta were not de
tected in any culture supernatant. No differences were noticed in the
patterns of cytokine secretion among the LCLs from HIV-seropositive pa
tients and in those raised from patients with primary EBV infections o
r obtained by infecting normal B cells in vitro with EBV. It is tempti
ng to speculate that abnormally expanded EBV-harboring B cells in HIV-
seropositive patients may participate in the pathogenesis of certain c
linical manifestations by releasing inflammatory cytokines; some of th
ese cytokines might also contribute to the in vivo spreading of HIV in
fection. However, the spontaneous LCLs from HIV-seropositive individua
ls do not display abnormal features compared to latently HIV-infected
LCLs from other sources despite the high frequency of EBV-driven lymph
oproliferative disorders observed in AIDS patients. (C) 1995 Academic
Press, Inc.